— Know what they know.
Not Investment Advice
APYX (NASDAQ) is a cross-listing of BVX (NASDAQ). Showing primary listing data.

BVX

Apyx Medical Corporation
1W: +25.8% 1M: +1.7% 3M: -8.7% 1Y: +147.3% 3Y: +222.4% 5Y: +214.6%
$6.48
Last traded 2018-12-31 — delisted
NASDAQ · Healthcare · Medical - Devices
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range7.7-2.28
Volume129,971
Avg Volume139,104
Beta1.11
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOCharles D. Goodwin II
Employees220
SectorHealthcare
IndustryMedical - Devices
IPO Date1987-01-01
5115 Ulmerton Road
Clearwater, FL 33760
US
727 384 2323
About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Recent Insider Trades

NameTypeSharesPriceDate
Swandal Craig A. 12,000 $2.37 2019-03-09
Semb Tara 0 2019-01-02
MAKRIDES ANDREW G-Gift 2,000 $6.84 2018-11-08
MAKRIDES ANDREW G-Gift 2,000 $6.84 2018-11-08
MAKRIDES ANDREW G-Gift 2,000 $6.84 2018-11-08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms